AMAntoine E. Melkane

Antoine E. Melkane

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Antoine E. Melkane has a total of 100 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Pharyngocutaneous Fistula After Total Laryngectomy: IFOS Consensus on Prevention, Diagnosis, and Management

    by Antonino Maniaci, Carlos Chiesa‐Estomba, Aleix Rovira, Antoine Melkane, Armando De Virgilio, Bernard Lyons, Aina Brunet, Christian Calvo Henríquez, Enyi Ofo, Federica Maria Parisi, et al.

    Importance: Significant international variations exist for prevention methods, diagnostic, and management criteria for pharyngocutaneous fistula. Objective: To formulate best practice management guidelines for pharyngocutaneous fistula after total laryngectomy. Design: Modified Delphi consensus study conducted between January 2024 and November 2025 using two rounds of a structured survey. Levels of consensus were evaluated through a 9‐point Likert scale and predefined cutoffs: strong consensus (≥ 80% in 7–9 range, median ≥ 9), consensus (≥ 80% in 7–9 range, median 8–9), near‐consensus (≥ 70% in 7–9 range), or no‐consensus (< 70% agreement). Setting: International multicenter study. Participation of experts from 18 countries of America, Europe, Asia, South America, and Oceania, under the guidance of the International Federation of Oto‐rhino‐laryngological Societies (IFOS). Participants: A multidisciplinary international panel of 36 experts in head and neck surgery, otolaryngology, radiation oncology, radiology, and plastic surgery. The panelists were chosen for their clinical expertise in the area of total laryngectomy and pharyngocutaneous fistula management; published work in the form of peer‐reviewed publications, as well as geographical representation. Main Outcomes and Measures: The level of consensus in 59 statements regarding fistula definition and classification, preoperative risk factors, prevention strategies, diagnostic modalities, conservative management protocols, surgical intervention criteria, nutritional support, and patient outcomes. Results: A consensus or strong consensus was reached on 30 of 59 statements (50.8%). Strong consensus levels were reached for preoperative nutrition optimization (median 9.0), postoperative enteral feeding support (median 9.0), standardized surveillance protocols (median 9.0), and revision surgery for persisting fistulae (median 9.0). Consensus was also achieved for the use of vascularized tissue reinforcement in selected high‐risk settings, although the preferred reconstructive strategy varied according to flap type and clinical scenario. Of the 29 statements, 5 (8.5%) were excluded at Round 1 as a result of conceptual repetition as highlighted by panel feedback, and 24 (40.7%) did not reach consensus after both rounds, including fistula classification systems, prophylactic salivary bypass tubes, time to resume oral feeding postoperatively and negative pressure wound therapy. Conclusions and Relevance: This Delphi study from an international panel provides areas of agreement and ongoing equipoise across the prevention, diagnosis, and management of PCF, while demonstrating significant practice variability in terms of their classification, the use of prophylactic interventions, and conservative therapies.

  • Open Access

    Objective assessment of surgical performance in otolaryngology residency

    by Antoine E. Melkane, Nadim Khoueir, Simon Rassi

    A surgeon's technical competence is a key predictor of surgical outcomes, yet residents' performance is often assessed by direct observation withou

  • Adjuvant radiation therapy in the management of nasal vestibule squamous cell carcinoma: a systematic review and meta-analysis

    by Jean-Marie Moukarzel, Mikhael Makhoul, Patrick El Khoury, Christopher El Hadi, Antoine E. Melkane

    Nasal vestibule squamous cell carcinoma (NVSCC) is a rare malignancy, accounting for less than 1% of head and neck cancers. Its rarity and distinct anatomical location pose management challenges, with limited high-quality evidence guiding treatment. Early-stage NVSCC is often managed with surgery or radiation therapy (RT) alone, while advanced cases may benefit from surgical resection followed by adjuvant RT. This systematic review and meta-analysis synthesize evidence on adjuvant RT in NVSCC, focusing on indications, doses, recurrence, and survival outcomes. A systematic search of MEDLINE, EMBASE, Scopus, and CENTRAL up to February 2024 identified eligible prospective or retrospective studies reporting outcomes of NVSCC treated with adjuvant RT. Data on patient demographics, staging, radiotherapy details, toxicities, recurrence, and survival outcomes were extracted. Meta-analysis was performed using logit-transformed proportions with fixed- and random-effects models. Subgroup analysis and meta-regression explored dose and staging effects. Eighteen studies involving 1,052 patients were included, with 170 receiving adjuvant RT. Indications included positive margins, advanced stages, and pathological features such as perineural invasion. RT doses ranged from 50 to 80 Gy, with a mean of 60 Gy. The pooled locoregional recurrence rate was 24.9%, and 5-year disease-specific survival reached 88.1%. Subgroup analyses showed no statistically significant differences by dose or fractionation. Toxicities were variably reported, with some studies noting radionecrosis, fistulas, and cosmetic complications. Adjuvant RT may offer clinical benefit in selected high-risk NVSCC cases, but evidence quality is low and heterogeneous. Standardized staging systems and prospective studies are needed to optimize treatment recommendations.

  • Open Access

    A massive multicystic parapharyngeal tumor: A case report

    by Patrick EL Khoury, Rhea Khazen, Antoine E. Melkane


  • Management of oral feeding following total laryngectomy around the world: YO‐IFOS international study

    by Johanna Benali, Gerrit Viljoen, Tareck Ayad, Robinson Gravier‐Dumonceau, Fabio Pupo Ceccon, Napadon Tangjaturonrasme, Alberto Maria Saibene, Carlos Chiesa‐Estomba, Antoine E. Melkane, Jacqueline Allen, et al.

    Background: To analyze worldwide practices regarding the initiation of oral feeding after total laryngectomy (TL).Methods: Online survey.Results: Among the 332 responses received, 278 from 59 countries were analyzed. Our results showed that 45.6% of respondents started water and 45.1% started liquid diet between postoperative days 7 and 10. Semi‐solid feeds were initiated between days 10 and 14 for 44.9% of respondents and a free diet was allowed after day 15 for 60.8% of respondents. This timing was significantly delayed in cases of laryngo‐pharyngectomy and after prior radiotherapy (p < 0.001). A greater proportion of respondents in Africa and Oceania allowed early oral feeding before day 6 as compared with the rest of the world (p < 0.001).Conclusion: Despite increasing number of publications, there is still a lack of evidence to support early oral feeding. The majority of respondents preferred to delay its initiation until at least 7 days after surgery.


  • Manifestations ORL de la maladie de Forestier : revue systématique de la littérature

    by Michel G. Khalaf, Patrick Cherfane, Hussein Smaily, Antoine E. Melkane

  • Otolaryngologic manifestations of diffuse idiopathic skeletal hyperostosis (Forestier's disease): A systematic review of the literature

    by Patrick Cherfane, Hussein Smaily, Michel G. Khalaf, Nohra Ghaoui, Antoine E. Melkane


  • An unusual metastatic submandibular gland tumor

    by M.G. Khalaf, H. Nassereddine, G. Chahine, A.E. Melkane


  • Surgical, clinical, and functional outcomes of transoral robotic surgery used in sleep surgery for obstructive sleep apnea syndrome: A systematic review and meta‐analysis

    by Jerome R. Lechien, Carlos‐Miguel Chiesa‐Estomba, Nicolas Fakhry, Sven Saussez, Ibrahim Badr, Tareck Ayad, Younes Chekkoury‐Idrissi, Antoine E. Melkane, Ahmed Bahgat, Lise Crevier‐Buchman, et al.

    We investigated safety and efficacy of transoral robotic surgery (TORS) for base of tongue (BOT) reduction in obstructive sleep apnea syndrome (OSAS) patients. PubMed, Cochrane Library, and Scopus were searched. A meta‐analysis was performed. Random effects models were used. Thirty‐one cohorts met our criteria (1693 patients). The analysis was based mostly on retrospective studies. The summary estimate of the reduction of Apnea–Hypoxia Index (AHI) was 24.25 abnormal events per hour (95% CI: 21.69–26.81) and reduction of Epworth Sleepiness Scale (ESS) was 7.92 (95% CI: 6.50–9.34). The summary estimate of increase in lowest O2 saturation was 6.04% (95% CI: 3.05–9.03). The success rate of TORS BOT reduction, either alone or combined with other procedures, was 69% (95% CI: 64–79). The majority of studies reported low level of evidence but suggested that TORS BOT reduction may be a safe procedure associated with improvement of AHI, ESS, and lowest O2 saturation.